| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Greenwich Lifesciences, Inc. (GLSI) has 1 insider with recent SEC Form 4 filings, including 11 buys and 0 sells. GLSI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.60M | $127.89M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | $13.98 | $3,495.00 | - | |
| Nov 2, 2022 | Patel Snehal | CEO And CFO | Buy | 2,000 | $8.79 | $17,580.00 | - | |
| Oct 14, 2022 | Patel Snehal | CEO And CFO | Buy | 3,000 | $9.75 | $29,250.00 | +0.1% | |
| Oct 7, 2022 | Patel Snehal | CEO And CFO | Buy | 2,000 | $9.72 | $19,440.00 | - | |
| Sep 30, 2022 | Patel Snehal | CEO And CFO | Buy | 1,000 | $9.46 | $9,460.00 | - | |
| Sep 29, 2022 | Patel Snehal | CEO And CFO | Buy | 1,000 | $9.23 | $9,230.00 | - | |
| Jun 24, 2022 | Patel Snehal | CEO And CFO | Buy | 29,000 | $9.13 | $264,770.00 | +0.5% | |
| Jun 16, 2022 | Patel Snehal | CEO And CFO | Buy | 8,000 | $7.13 | $57,040.00 | +0.3% | |
| Jun 14, 2022 | Patel Snehal | CEO And CFO | Buy | 12,000 | $7.91 | $94,920.00 | +0.5% | |
| Jun 10, 2022 | Patel Snehal | CEO And CFO | Buy | 12,000 | $8.33 | $99,960.00 | +0.5% |